MedTrace Logo

Durg Coated Balloon Angioplasty in Infrapopliteal Lesions

NCT05620095 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-03-25

No results posted yet for this study

Summary

This study is a multicenter observational study designed to evaluate the the effectiveness and safety of drug-coated balloon (DCB) angioplasty for below the knee arterial lesions in patients critical with Limb Threatening Ischemia (CLTI).

Conditions

Interventions

DEVICE

drug-coated balloon

To evaluate the effectiveness and safety of drug-coated balloon angioplasty for infrapopliteal artery lesions in patients with CLTI.

Sponsors & Collaborators

  • Xuanwu Hospital, Beijing

    collaborator OTHER

  • RenJi Hospital

    collaborator OTHER

  • Zhejiang University

    collaborator OTHER

  • First People's Hospital of Hangzhou

    collaborator OTHER

  • Second Affiliated Hospital of Suzhou University

    collaborator OTHER

  • Qingdao University

    collaborator OTHER

  • Chengdu University of Traditional Chinese Medicine

    collaborator OTHER

  • Shanghai Zhongshan Hospital

    collaborator OTHER

  • Huashan Hospital

    collaborator OTHER

  • Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology

    lead OTHER

Principal Investigators

  • Zibo Feng · Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology

  • Lianrui Guo · Xuanwu Hospital, Beijing

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2025-11-01
Completion
2026-11-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05620095 on ClinicalTrials.gov